Findling Robert L, Horwitz Sarah McCue, Birmaher Boris, Kowatch Robert A, Fristad Mary A, Youngstrom Eric A, Frazier Thomas W, Axelson David, Ryan Neal, Demeter Christine A, Depew Judith, Fields Benjamin, Gill Mary Kay, Deyling Elizabeth A, Rowles Brieana M, Arnold L Eugene
University Hospitals Case Medical Center/Case Western Reserve University, Cleveland, OH 44106, USA.
J Child Adolesc Psychopharmacol. 2011 Aug;21(4):311-9. doi: 10.1089/cap.2010.0138.
This study explored the demographic and diagnostic features of children who were currently receiving antipsychotics compared to children who were receiving other psychotropics in a cohort of children with and without elevated symptoms of mania (ESM). Participants were recruited from 10 child outpatient mental health clinics associated with four universities. Guardians with children between 6-12 years who presented for new clinical evaluations completed the Parent General Behavior Inventory-10 Item Mania Scale (PGBI-10M). All children who scored ≥12 on the PGBI-10M and a select demographically matched comparison group of patients who scored ≤11 were invited to participate. Children were divided into two groups: those receiving at least one antipsychotic medication and those receiving other psychotropic medications. The groups were compared on demographics, diagnoses, psychiatric symptoms, functioning, and past hospitalizations. Of the 707 children enrolled in the Longitudinal Assessment of Manic Symptoms (LAMS) study, 443 (63%) were prescribed psychotropic medication at baseline: 157 (35%) were receiving an antipsychotic and 286 (65%) were prescribed other agents. Multivariate results indicated that being prescribed antipsychotics was related to being white, previous hospitalization, having a psychotic or bipolar 1 disorder and the site where the child was receiving services (p<0.001). In this sample, it is relatively common for a child to be prescribed an antipsychotic medication. However, the only diagnoses associated with a greater likelihood of being treated with an antipsychotic were psychotic disorders or unmodified DSM-IV bipolar 1 disorder.
本研究探讨了在一组有或没有躁狂症状加重(ESM)的儿童中,目前正在接受抗精神病药物治疗的儿童与接受其他精神药物治疗的儿童的人口统计学和诊断特征。参与者是从与四所大学相关的10家儿童门诊心理健康诊所招募的。带着6至12岁孩子前来进行新的临床评估的监护人完成了《父母一般行为量表-10项躁狂量表》(PGBI-10M)。所有在PGBI-10M上得分≥12的儿童以及一个按人口统计学特征匹配的、得分≤11的选定对照组患者被邀请参与。儿童被分为两组:一组接受至少一种抗精神病药物治疗,另一组接受其他精神药物治疗。对两组在人口统计学、诊断、精神症状、功能和既往住院情况方面进行了比较。在参与躁狂症状纵向评估(LAMS)研究的707名儿童中,443名(63%)在基线时被开具了精神药物:157名(35%)接受抗精神病药物治疗,286名(65%)被开具了其他药物。多变量结果表明,被开具抗精神病药物与白人、既往住院、患有精神病性或双相I型障碍以及儿童接受服务的地点有关(p<0.001)。在这个样本中,儿童被开具抗精神病药物相对较为常见。然而,与接受抗精神病药物治疗可能性更大相关的唯一诊断是精神病性障碍或未修订的《精神疾病诊断与统计手册》第四版双相I型障碍。